| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eyepoint, Inc. (EYPT) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 11 sells. EYPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 8.27M | $112.07M | - | |
| Dir | 294.3K | $3.99M | - | |
| Other | 87.8K | $1.19M | - | |
| Dir | 41.5K | $562.7K | - | |
| Dir | 40.0K | $542.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Lurker Nancy77 | Director | Buy | 3,173 | $7.88 | $25,003.24 | +3.4% | +32.3% | +39.8% | |
| Jul 12, 2024 | Guyer David R62 | Director | Sale+OE | 11,625 | $10.06 | $116,995.16 | -86.3% | -20.2% | +0.3% | |
| Jun 3, 2024 | Guyer David R62 | Director | Sale+OE | 11,625 | $10.30 | $119,704.95 | -75.9% | -17.5% | -17.8% | |
| May 14, 2024 | Guyer David R62 | Director | Sale+OE | 11,625 | $12.65 | $147,044.63 | -67.7% | -32.9% | -55.9% | |
| May 6, 2024 | Cormorant Asset Management, LP50 | - | Buy | 850,000 | $11.86 | $10,081,720.98 | +5.5% | -23.2% | -44.2% | |
| Apr 18, 2024 | Cormorant Asset Management, LP50 | - | Buy | 581,765 | $18.03 | $10,489,446.18 | +4.1% | -44.7% | -67.6% | |
| Feb 2, 2024 | Jones David Scott83 | SVP &Chief Commercial Officer | Sale+OE | 209 | $28.49 | $5,954.41 | -0.5% | -30.5% | -73.3% | |
| Jan 26, 2024 | Paggiarino Dario A.79 | Chief Medical Officer | Sale+OE | 49,325 | $25.66 | $1,265,538.97 | -20.4% | -38.9% | -67.8% | |
| Jan 26, 2024 | Jones David Scott83 | SVP &Chief Commercial Officer | Sale+OE | 26,017 | $25.38 | $660,370.49 | -23.3% | -38.9% | -67.8% | |
| Jan 25, 2024 | Paggiarino Dario A.79 | Chief Medical Officer | Sale+OE | 600 | $25.00 | $15,000.00 | -0.8% | -33.9% | -65.7% |